Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.12K Buy
13
+5
+63% +$468 ﹤0.01% 3207
2026
Q2
$692 Sell
8
-10
-56% -$854 ﹤0.01% 3227
2026
Q1
$1.61K Buy
18
+2
+13% +$192 ﹤0.01% 2916
2025
Q4
$1.49K Sell
16
-19
-54% -$2.07K ﹤0.01% 2843
2025
Q3
$4.36K Buy
35
+4
+13% +$509 ﹤0.01% 2392
2025
Q2
$4.08K Buy
31
+13
+72% +$1.47K ﹤0.01% 2191
2025
Q1
$1.89K Sell
18
-158
-90% -$16.5K ﹤0.01% 2182
2024
Q4
$19.1K Buy
176
+161
+1,073% +$18K ﹤0.01% 1666
2024
Q3
$1.6K Sell
15
-4
-21% -$405 ﹤0.01% 1917
2024
Q2
$1.88K Buy
+19
New +$1.91K ﹤0.01% 1757
2022
Q2
– Sell
-40
Closed -$2K – 1585
2022
Q1
$2K Buy
+40
New +$2.24K ﹤0.01% 1418
2018
Q1
– Sell
-16
Closed -$1K – 1688
2017
Q4
$1K Buy
16
+11
+220% +$786 ﹤0.01% 1632
2017
Q3
$0 Buy
+5
New +$363 ﹤0.01% 1540

Other funds holding ITRI

AssetMark's ITRI Position: Q3 2026 in Review

AssetMark increased its Itron (ITRI) stake by 63% in Q3 2026, buying an estimated $468 and bringing the position to 13 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

AssetMark first reported a position in ITRI in Q3 2017 and has held it in 13 quarters since. The position peaked at $19.1K in Q4 2024. 336 funds tracked by Wall St. Rank hold ITRI as of Q3 2026.

  • AssetMark held 13 shares of Itron worth $1.12K as of Q3 2026.
  • AssetMark bought 5 Itron shares in Q3 2026, an estimated $468.
  • Itron made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3207 holding.
  • AssetMark first reported a position in Itron in Q3 2017 and has held it in 13 quarters since.
  • AssetMark's Itron position peaked at $19.1K in Q4 2024.
  • 336 funds tracked by Wall St. Rank held Itron as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.